RxDoctor Payments Data

Christian Eversull

Internal Medicine · Stanford, CANPI 1609054006

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,760,011 of the $2,896,305 with a category attached, or 95.3%. Medtronic accounts for 95.3% of it on its own, with 1 other manufacturer making up the rest. 2024 is the largest year on record at $2,789,461, more than ten times the $67,210 reported in 2021. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,896,305in general payments, 2019–2025

Across 9 payments — averaging $321,812 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2.8M
  • Boston Scientific$136K

What the payments were for

  • Royalty or licence$2,760,01195%
  • Education$700%
  • Other$136,2245%

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic3$2,760,081
Boston Scientific6$136,224

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,896,305 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Other internal medicine in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →